Huadong Medicine Co., Ltd (000963.SZ)
000963.SZ Stock Price Chart
Explore Huadong Medicine Co., Ltd interactive price chart. Choose custom timeframes to analyze 000963.SZ price movements and trends.
000963.SZ Company Profile
Discover essential business fundamentals and corporate details for Huadong Medicine Co., Ltd (000963.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
27 Jan 2000
Employees
18.27K
Website
https://www.eastchinapharm.comCEO
Liang Lv
Description
Huadong Medicine Co., Ltd produces and sells various pharmaceutical products in China. It offers Chinese patent drugs, immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, medical cosmetology, and antibiotic drugs, as well as medical equipment. The company's products include gastrointestinal agents, APIs, and other products. It also engages in the production and management of traditional Chinese and western raw medicines and preparations, and health care products; wholesale of TCM materials, TCM decoction pieces, chemical preparations, etc.; warehousing and storage business; and research, development, production, and sale of aesthetic medicine products. Huadong Medicine Co., Ltd was founded in 1993 and is headquartered in Hangzhou, China.
000963.SZ Financial Timeline
Browse a chronological timeline of Huadong Medicine Co., Ltd corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 19 Aug 2025
EPS came in at ¥0.51 surpassing the estimated ¥0.50 by +2.00%, while revenue for the quarter reached ¥10.94B , missing expectations by -0.01%.
Dividend declared on 5 Jun 2025
A dividend of ¥0.58 per share was announced, adjusted to ¥0.58. The dividend was paid on 5 Jun 2025.
Earnings released on 24 Apr 2025
EPS came in at ¥0.52 matching the estimated ¥0.52, while revenue for the quarter reached ¥10.74B , missing expectations by -8.56%.
Earnings released on 17 Apr 2025
EPS came in at ¥0.54 surpassing the estimated ¥0.43 by +25.58%, while revenue for the quarter reached ¥10.43B , missing expectations by -10.14%.
Earnings released on 24 Oct 2024
EPS came in at ¥0.50 surpassing the estimated ¥0.48 by +4.17%, while revenue for the quarter reached ¥10.51B , missing expectations by -4.27%.
Dividend declared on 20 Sept 2024
A dividend of ¥0.35 per share was announced, adjusted to ¥0.35. The dividend was paid on 20 Sept 2024.
Earnings released on 15 Aug 2024
EPS came in at ¥0.48 surpassing the estimated ¥0.45 by +6.67%, while revenue for the quarter reached ¥10.50B , missing expectations by -2.04%.
Dividend declared on 28 May 2024
A dividend of ¥0.58 per share was announced, adjusted to ¥0.58. The dividend was paid on 28 May 2024.
Earnings released on 26 Apr 2024
EPS came in at ¥0.49 surpassing the estimated ¥0.46 by +6.52%, while revenue for the quarter reached ¥10.35B , missing expectations by -5.08%.
Earnings released on 18 Apr 2024
EPS came in at ¥0.37 surpassing the estimated ¥0.36 by +2.78%, while revenue for the quarter reached ¥10.15B , beating expectations by +4.52%.
Earnings released on 24 Oct 2023
EPS came in at ¥0.43 surpassing the estimated ¥0.41 by +4.88%, while revenue for the quarter reached ¥10.01B , missing expectations by -6.24%.
Earnings released on 15 Aug 2023
EPS came in at ¥0.39 surpassing the estimated ¥0.38 by +2.63%, while revenue for the quarter reached ¥10.27B , missing expectations by -2.04%.
Dividend declared on 14 Jun 2023
A dividend of ¥0.29 per share was announced, adjusted to ¥0.29. The dividend was paid on 14 Jun 2023.
Earnings released on 21 Apr 2023
EPS came in at ¥0.43 falling short of the estimated ¥0.46 by -6.52%, while revenue for the quarter reached ¥9.86B , missing expectations by -3.75%.
Earnings released on 14 Apr 2023
EPS came in at ¥0.30 matching the estimated ¥0.30, while revenue for the quarter reached ¥10.11B , missing expectations by -0.23%.
Earnings released on 25 Oct 2022
EPS came in at ¥0.37 falling short of the estimated ¥0.39 by -5.13%, while revenue for the quarter reached ¥9.66B , beating expectations by 0.00%.
Earnings released on 9 Aug 2022
EPS came in at ¥0.36 surpassing the estimated ¥0.35 by +2.86%, while revenue for the quarter reached ¥9.27B , missing expectations by -5.56%.
Dividend declared on 13 Jun 2022
A dividend of ¥0.29 per share was announced, adjusted to ¥0.29. The dividend was paid on 13 Jun 2022.
Earnings released on 28 Apr 2022
EPS came in at ¥0.40 falling short of the estimated ¥0.42 by -4.76%, while revenue for the quarter reached ¥8.93B , missing expectations by -22.38%.
Earnings released on 28 Apr 2022
EPS came in at ¥0.23 falling short of the estimated ¥0.32 by -28.13%, while revenue for the quarter reached ¥8.64B .
Earnings released on 27 Oct 2021
EPS came in at ¥0.34 surpassing the estimated ¥0.28 by +21.43%, while revenue for the quarter reached ¥8.75B , beating expectations by +21.43%.
Earnings released on 9 Aug 2021
EPS came in at ¥0.31 falling short of the estimated ¥0.47 by -34.04%, while revenue for the quarter reached ¥8.28B .
Dividend declared on 9 Jun 2021
A dividend of ¥0.23 per share was announced, adjusted to ¥0.23. The dividend was paid on 9 Jun 2021.
Earnings released on 27 Apr 2021
EPS came in at ¥0.43 falling short of the estimated ¥0.51 by -15.69%, while revenue for the quarter reached ¥8.90B .
Earnings released on 21 Apr 2021
EPS came in at ¥0.25 surpassing the estimated ¥0.20 by +25.00%, while revenue for the quarter reached ¥8.18B .
Earnings released on 26 Oct 2020
EPS came in at ¥0.38 falling short of the estimated ¥0.40 by -5.00%, while revenue for the quarter reached ¥8.84B .
000963.SZ Stock Performance
Access detailed 000963.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.